Horizons ETFs Made Waves When They Launched the World’s First Psychedelics Stock ETF on the NEO Exchange Early This Year
The Dales Report sat down with Steve Hawkins, the President and CEO of Horizons ETFs for an interview, to learn a little bit more about the behind-the-scenes on creating a Psychedelics ETF like
Horizons Psychedelic Stock Index ETF (NEO: PSYK) from scratch, what investors should know, and where the Psychedelics industry – and others – might be headed. Right now, Hawkings says, the psychedelics industry resembles Cannabis in capital market structure. There’s very few companies in the space, but with big IPOs, and multiple U.S. companies that are looking at moving into Canadian space.
MONEYWEB
app instead?
Developments show that global receptiveness to marijuana is accelerating.
By Tiffany Kary, Bloomberg
15 Mar 2021 07:45
Seemingly overnight, the cannabis industry has gone global.
That can be seen in the deal just announced by Curaleaf Holdings Inc., the largest US cannabis company, that aims to turn Europe into a launchpad for international growth. Or take a look at British American Tobacco Plcâs new stake in a Canadian marijuana company, Organigram Holdings Inc. And then thereâs the bill passed last week in Mexico that could make recreational marijuana legal, paving the way for heavy international investment.
Together, the developments show that global receptiveness to marijuana is accelerating.
Marijuana Is Going Global at a Rapid Pace: Cannabis Weekly leaderpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from leaderpost.com Daily Mail and Mail on Sunday newspapers.
Cannabis Curaleaf in $286 Million deal to expand in Europe.
Curaleaf, the largest cannabis company in the U.S., is on its way to become the largest of its kind in the world after announcing a $286 million deal to acquire European marijuana company Emmac Life Sciences.
Boris Jordan, the billionaire executive chairman of Curaleaf, said during the company’s earning’s call on Tuesday that the acquisition is a “transformational launching point” and will turn the company into a dominant force in the global cannabis industry.
Jordan, who owns a $2.5 billion stake in the company, said Europe is part of the company’s long-term growth strategy. Jordan explained during Curaleaf’s earnings call that Europe’s population of 743 million is more than twice of the U.S. and the continent will eventually provide a total addressable market of $120 billion.
Mar 12, 2021 09:10 pm
By Chloe Aiello
Share with
U.S. cannabis company Curaleaf agreed to acquire London-based Emmac Life Sciences in a $286 million deal that represents the company’s first step into the burgeoning European cannabis market.
“We think, although the market is just emerging, it s the addressable opportunity in Europe could actually be bigger than the addressable opportunity in the U.S., and this gives us an unparalleled platform to be able to build on,” Curaleaf CEO Joe Bayern told Cheddar.
The cash and stock transaction is expected to close early in the second quarter of 2021.
Cannabis multistate operator Curaleaf already has a substantial presence across the U.S. market. Following its $830 million acquisition of Grassroots Cannabis, which closed in July, the company has a footprint across 23 U.S. states including Arizona and New Jersey, where voters recently approved adult-use legalization. The Emmac acquisition grants Curaleaf access to the expanding Euro